Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KIAA1755 encodes an uncharacterized human protein consisting of approximately 1,200 amino acids[6]. It is a protein-coding gene with expression in the brain and other tissues, but the precise biological and molecular roles have not been fully elucidated[1][9]. The protein is predicted to have guanyl-nucleotide exchange factor activity and is possibly involved in axon guidance, functioning in the cytoplasm and associated with the plasma membrane, but definitive molecular function, clinical significance, and druggability remain undetermined[1][13][15]. Currently, KIAA1755 is not established as a therapeutic target, and there are no known drugs or specific disease biomarker roles, though some database associations link it to prostate cancer[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Uncharacterized protein KIAA1755 (KIAA1755).